Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Biomarkers kunnen 'Lewy body'-dementie van Alzheimer onderscheiden
okt 2023 | Dementie